Asset Management One’s PDL BioPharma, Inc. PDLI Stock Holding History

Asset Management One’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-96,498	Closed	-$359K	–	1117
2019 Q1	$359K	Buy	+96,498	New	+$326K	﹤0.01%	981
2016 Q4	–	Sell	-431,141	Closed	-$1.44M	–	1402
2016 Q3	$1.44M	Hold	431,141	–	–	0.02%	721
2016 Q2	$1.35M	Hold	431,141	–	–	0.02%	745
2016 Q1	$1.44M	Hold	431,141	–	–	0.02%	741
2015 Q4	$1.53M	Buy	431,141 +236,220	+121%	+$989K	0.02%	719
2015 Q3	$980K	Sell	194,921 -64,157	-25%	-$368K	0.01%	861
2015 Q2	$1.67M	Sell	259,078 -22,620	-8%	-$152K	0.02%	716
2015 Q1	$1.98M	Buy	281,698 +132,100	+88%	+$957K	0.02%	689
2014 Q4	$1.15M	Hold	149,598	–	–	0.02%	809
2014 Q3	$1.12M	Sell	149,598 -251,162	-63%	-$2.33M	0.02%	779
2014 Q2	$3.87M	Buy	400,760 +343,836	+604%	+$3.06M	0.06%	367
2014 Q1	$473K	Sell	56,924 -328,099	-85%	-$2.81M	0.01%	929
2013 Q4	$3.23M	Buy	385,023 +43,111	+13%	+$363K	0.05%	386
2013 Q3	$2.8M	Hold	341,912	–	–	0.04%	421
2013 Q2	$2.62M	Buy	+341,912	New	+$2.67M	0.04%	398

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Asset Management One's PDLI Position: Q2 2019 in Review

Asset Management One sold out of PDL BioPharma, Inc. (PDLI) in Q2 2019, closing a stake of 96,498 shares — an estimated $359K sold.

Asset Management One first reported a position in PDLI in Q2 2013 and held it in 15 quarters. The position peaked at $3.87M in Q2 2014. 148 funds tracked by Wall St. Rank hold PDLI as of Q2 2019.

Asset Management One reported no remaining PDL BioPharma, Inc. position as of Q2 2019 after selling out during the quarter.
Asset Management One sold 96,498 PDL BioPharma, Inc. shares in Q2 2019, an estimated $359K.
Asset Management One first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 15 quarters.
Asset Management One's PDL BioPharma, Inc. position peaked at $3.87M in Q2 2014.
148 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2019.

Based on Asset Management One's 13F filing for Q2 2019, filed 14 Aug 2019.